J.W. Cole Advisors, Inc. Abbott Laboratories Transaction History

J.W. Cole Advisors, Inc.

$2.09 Billion
Q2 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 23,702 shares of ABT stock, worth $2.69 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

23,702

Previous 20,692 14.55%

Holding current value

$2.69 Million

Previous $2.35 Million 4.72%

% of portfolio

0.12%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $303,197 - $338,444	3,010 Added 14.55%	23,702 $2.46 Million
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $218,492 - $241,315	1,995 Added 10.67%	20,692 $2.35 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $43,471 - $53,212	-482 Reduced 2.51%	18,697 $2.06 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $166,126 - $199,324	1,739 Added 9.97%	19,179 $1.86 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $393,142 - $438,043	-3,901 Reduced 18.28%	17,440 $1.9 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $238,856 - $281,148	2,466 Added 13.06%	21,341 $2.16 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $258,943 - $303,780	-2,724 Reduced 12.61%	18,875 $2.07 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $160,428 - $185,745	-1,658 Reduced 7.13%	21,599 $2.09 Million
Q2 2022 Jul 27, 2022	BUY	$102.07 - $123.37 $200,261 - $242,051	1,962 Added 9.21%	23,257 $2.53 Million
Q1 2022 Jun 10, 2022	SELL	$114.02 - $139.04 $167 Million - $204 Million	-1,468,477 Reduced 98.57%	21,295 $2.52 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $168 Million - $205 Million	1,470,810 Added 7756.62%	1,489,772 $1.07 Million
Q4 2021 Jan 25, 2022	SELL	$115.53 - $141.46 $14,441 - $17,682	-125 Reduced 0.65%	18,962 $2.67 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $137,425 - $152,032	1,178 Added 6.58%	19,087 $2.26 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $144,509 - $170,107	1,366 Added 8.26%	17,909 $2.08 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $52,352 - $61,678	481 Added 2.99%	16,543 $1.98 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.6 Million - $1.75 Million	-15,252 Reduced 48.71%	16,062 $1.76 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $1.26 Million - $1.53 Million	13,771 Added 78.5%	31,314 $3.41 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $1.34 Million - $1.72 Million	17,543 New	17,543 $1.6 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $721,236 - $1.05 Million	-11,481 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $901,373 - $1 Million	11,481 New	11,481 $997,000

Others Institutions Holding ABT

# of Institutions

3,134

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Abbott Laboratories Transaction History